表紙:世界の臨床診断市場の競合分析・成長予測・成長機会 (~2026年):検査タイプ・製品・用途・エンドユーザー・地域別
市場調査レポート
商品コード
984758

世界の臨床診断市場の競合分析・成長予測・成長機会 (~2026年):検査タイプ・製品・用途・エンドユーザー・地域別

Global Clinical Diagnostics Market By Type of Test, By Product, By Application, By End-User By Region, Competition, Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 110 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.81円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

世界の臨床診断市場の競合分析・成長予測・成長機会 (~2026年):検査タイプ・製品・用途・エンドユーザー・地域別
出版日: 2021年01月01日
発行: TechSci Research
ページ情報: 英文 110 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床診断の市場規模は2020年に約560億米ドルを示し、予測期間中は8.59%の安定したCAGRで成長すると予測されています。糖尿病、心血管疾患、高血圧、脂質障害などの座りがちな生活に起因する疾患の有病率の増加、慢性腎臓病や癌の患者数の増加などの要因が同市場の成長を推進しています。

検査タイプ別で見ると、脂質パネルの部門が市場をリードする見通しです。肥満や座りがちな生活に起因する疾患への罹患患者の増加から、心血管疾患のリスクの拡大やコレステロール値の上昇などの要因が同部門の成長を牽引しています。また、成長率では、新型コロナウイルス感染症 (COVID-19) の影響から、感染症の部門が最大の成長を示す見通しです。

当レポートでは、世界の臨床診断の市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、世界および地域・国別の市場規模および市場シェアの推移・予測、検査タイプ・製品・用途・エンドユーザーなど各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 検査タイプ別
    • 脂質パネル
    • 代謝パネル
    • 全血球計算
    • 感染症テスト
    • その他
  • 製品別
    • 機器
    • 試薬
    • ソフトウェア・サービス
    • アッセイ・キット
  • 用途別
    • 感染症
    • 心血管
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 診断ラボ
    • その他
  • 企業別
  • 地域別
  • 製品市場マップ

第6章 アジア太平洋市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • エンドユーザー別
  • 国別

第7章 欧州市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • エンドユーザー別
  • 国別

第8章 北米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • エンドユーザー別
  • 国別

第9章 南米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • エンドユーザー別
  • 国別

第10章 中東・アフリカ市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 検査タイプ別
  • 製品別
  • 用途別
  • エンドユーザー別
  • 国別

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向

第13章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • Abbott Laboratories
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Thermo Fisher Scientific Inc.
    • Sysmex Corporation
    • DiaSorin SpA

第14章 戦略的提言

第15章 当社について・免責事項

図表

List of Figures

  • Figure 1: Global Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
  • Figure 3: Global Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
  • Figure 4: Global Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
  • Figure 6: Global Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
  • Figure 7: Global Clinical Diagnostic Market Share, By Region (USD Million), 2016-2026F
  • Figure 8: Global Clinical Diagnostic Market Share, By Company (USD Million), 2016-2026F
  • Figure 9: Global Clinical Diagnostic Market Attractiveness Index, By Region, By Value, 2016-2026F
  • Figure 10: Global Clinical Diagnostic Market Attractiveness Index, By Product Type, By Value, 2016-2026F
  • Figure 11: North America Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 12: North America Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
  • Figure 13: North America Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
  • Figure 14: North America Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
  • Figure 15: North America Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
  • Figure 16: North America Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
  • Figure 17: North America Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 18: North America Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 19: United States Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 20: United States Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 21: United States Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 22: United States Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 23: United States Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 24: United States Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 25: Canada Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 26: Canada Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 27: Canada Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 28: Canada Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 29: Canada Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 30: Canada Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 31: Mexico Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 32: Mexico Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 33: Mexico Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 34: Mexico Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 35: Mexico Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 36: Mexico Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 37: Europe Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 38: Europe Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
  • Figure 39: Europe Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
  • Figure 40: Europe Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
  • Figure 41: Europe Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
  • Figure 42: Europe Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
  • Figure 43: Europe Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 44: Europe Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 45: France Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 46: France Kingdom Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 47: France Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 48: France Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 49: France Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 50: France Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 51: Germany Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 52: Germany Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 53: Germany Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 54: Germany Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 55: Germany Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 56: Germany Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 57: United Kingdom Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 58: United Kingdom Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 59: United Kingdom Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 60: United Kingdom Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 61: United Kingdom Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 62: United Kingdom Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 63: Italy Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 64: Italy Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 65: Italy Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 66: Italy Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 67: Italy Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 68: Italy Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 69: Spain Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 70: Spain Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 71: Spain Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 72: Spain Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 73: Spain Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 74: Spain Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 75: Russia Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 76: Russia Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 77: Russia Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 78: Russia Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 79: Russia Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 80: Russia Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 81: Asia-Pacific Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 82: Asia-Pacific Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
  • Figure 83: Asia-Pacific Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
  • Figure 84: Asia-Pacific Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
  • Figure 85: Asia-Pacific Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
  • Figure 86: Asia-Pacific Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
  • Figure 87: Asia-Pacific Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 88: Asia-Pacific Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 89: Japan Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 90: Japan Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 91: Japan Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 92: Japan Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 93: Japan Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 94: Japan Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 95: China Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 96: China Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 97: China Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 98: China Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 99: China Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 100: China Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 101: India Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 102: India Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 103: India Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 104: India Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 105: India Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 106: India Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 107: South Korea Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 108: South Korea Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 109: South Korea Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 110: South Korea Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 111: South Korea Clinical Diagnostic Market Share, By End-user, 2016-2026F
  • Figure 112: South Korea Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 113: Australia Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 114: Australia Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 115: Australia Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 116: Australia Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 117: Australia Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 118: Australia Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 119: Singapore Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 120: Singapore Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 121: Singapore Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 122: Singapore Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 123: Singapore Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 124: Singapore Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 125: Middle East and Africa Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 126: Middle East and Africa Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
  • Figure 127: Middle East and Africa Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
  • Figure 128: Middle East and Africa Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
  • Figure 129: Middle East and Africa Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
  • Figure 130: Middle East and Africa Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
  • Figure 131: Middle East and Africa Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 132: Middle East and Africa Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 133: South Africa Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 134: South Africa Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 135: South Africa Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 136: South Africa Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 137: South Africa Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 138: South Africa Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 139: SAUDI ARABIA Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 140: SAUDI ARABIA Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 141: SAUDI ARABIA Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 142: SAUDI ARABIA Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 143: SAUDI ARABIA Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 144: SAUDI ARABIA Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 145: UAE Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 146: UAE Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 147: UAE Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 148: UAE Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 149: UAE Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 150: UAE Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 151: Kuwait Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 152: Kuwait Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 153: Kuwait Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 154: Kuwait Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 155: Kuwait Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 156: Kuwait Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 157: South America Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 158: South America Clinical Diagnostic Market Size, By Type of Test (USD Million), 2016-2026F
  • Figure 159: South America Clinical Diagnostic Market Share, By Product (USD Million), 2016-2026F
  • Figure 160: South America Clinical Diagnostic Market Share, By Application (USD Million), 2016-2026F
  • Figure 161: South America Clinical Diagnostic Market Share, By End-User (USD Million), 2016-2026F
  • Figure 162: South America Clinical Diagnostic Market Share, By Country (USD Million), 2016-2026F
  • Figure 163: South America Clinical Diagnostic Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 164: South America Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 165: Brazil Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 166: Brazil Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 167: Brazil Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 168: Brazil Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 169: Brazil Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 170: Brazil Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 171: Argentina Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 172: Argentina Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 173: Argentina Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 174: Argentina Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 175: Argentina Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 176: Argentina Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
  • Figure 177: Colombia Clinical Diagnostic Market Size, By Value (USD Million), 2016-2026F
  • Figure 178: Colombia Clinical Diagnostic Market Size, By Type of Test, 2016-2026F
  • Figure 179: Colombia Clinical Diagnostic Market Share, By Product, 2016-2026F
  • Figure 180: Colombia Clinical Diagnostic Market Share, By Application, 2016-2026F
  • Figure 181: Colombia Clinical Diagnostic Market Share, By End-User, 2016-2026F
  • Figure 182: Colombia Clinical Diagnostic Market Attractiveness Index, By Product, By Value, 2016-2026F
目次
Product Code: 4519

Title:
Global Clinical Diagnostics
Market By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Assays and Kits, Software & Services), By Application (Infectious Disease, Cardiovascular, Cancer, Others), By End-User (Diagnostic Laboratory, Hospital & Clinics, Others) By Region, Competition, Forecast & Opportunities, 2026.

The global clinical diagnostics market was valued at around USD 56 billion in 2020 and is expected to grow at a steady CAGR of 8.59% during the forecast period. The global clinical diagnostics market is driven by increasing prevalence of diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, among others. Furthermore, increase in the number of patients suffering from chronic kidney diseases and cancer is also expected to drive the market for clinical diagnostics during the forecast years. Additionally, benefits such as quick test results, easy procedure of testing, ease of procurement of samples, less pain, among others associated with clinical diagnostics are further anticipated to propel the market through 2026.

Clinical diagnostics includes medical tests that are performed in a pathology or a diagnostic center or hospital or any other medical facility to diagnose or detect any disease or any other medical conditions. These tests help in early detection of a disease and identify the associated risk factors thereby creating opportunities for prevention and treatment.

The global clinical diagnostic market can be segmented based on type of test, product, application, end-user, company and region. Based on type of test, the market can be fragmented into lipid panel, metabolic panel, infectious disease testing, complete blood count and others. The lipid panel type of test segment is expected to dominate the market during forecast period owing to the significant increase in the number of people suffering from diseases caused due to obesity and sedentary lifestyle. Additionally, growing risks of cardiovascular diseases and cholesterol related problems is further driving the growth of this segment across the globe. Infectious disease segment is expected to exhibit the highest growth due to increase in prevalence of COVID-19. Based on product, the market can be categorized into instruments, reagents, assays and kits, and software & services. The assays and kits segment is expected to hold a significant market share over the next five years. This can be accredited to the increasing use of assays and kits for COVID-19 testing and in point of care and self-testing product kits.

Among all the regions, North America is expected to dominate the market through 2026. This can be attributed to the increasing health awareness among the population pertaining to the benefits of these tests and flourishing healthcare industry in the region. Asia -Pacific is expected to grow at the highest CAGR due to increasing investments by leading global players as well as and government initiatives.

Major players operating in the global clinical diagnostics market include Abbott Laboratories, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic, Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, DiaSorin SpA, among others.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of global clinical diagnostics market.
  • To classify and forecast global clinical diagnostics market based on type of test, product, application, End-User, and regional distribution.
  • To identify drivers and challenges for global clinical diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global clinical diagnostics market.
  • To conduct pricing analysis for global clinical diagnostics market.
  • To identify and analyze the profile of leading players operating in global clinical diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of major diagnostic players and hospital chains operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global clinical diagnostics market using a bottom-up approach, wherein data for various End-User segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Clinical diagnostics hospitals, diagnostic laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to clinical diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, diagnostic laboratories and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global clinical diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type of Test:

Lipid Panel

Metabolic Panel

Infectious Disease Testing

Complete Blood Count

Others

  • Market, By Product:

Instruments

Reagents

Assays and Kits

Software & Services

  • Market, By Application:

Infectious Disease

Cardiovascular

Cancer

Others

  • Market, By End-User:

Hospital & Clinics

Diagnostic Laboratory

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in global clinical diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Clinical Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others)
    • 5.2.2. By Product (Instruments, Reagents, Software & Services, Assays & Kits)
    • 5.2.3. By Application (Infectious Diseases, Cardiovascular, Cancer and Others)
    • 5.2.4. By End-User (Hospital & Clinics, Diagnostic Laboratory, Others)
    • 5.2.5. By Company (2020)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Clinical Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Test
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. Japan Clinical Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Test
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Product
        • 6.3.1.2.4. By End-User
    • 6.3.2. China Clinical Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Test
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Product
        • 6.3.2.2.4. By End-User
    • 6.3.3. India Clinical Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Test
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Product
        • 6.3.3.2.4. By End-User
    • 6.3.4. South Korea Clinical Diagnostics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type of Test
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By Product
        • 6.3.4.2.4. By End-User
    • 6.3.5. Australia Clinical Diagnostics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type of Test
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By Product
        • 6.3.5.2.4. By End-User
    • 6.3.6. Singapore Clinical Diagnostics Market Outlook
      • 6.3.6.1. Market Size & Forecast
        • 6.3.6.1.1. By Value
      • 6.3.6.2. Market Share & Forecast
        • 6.3.6.2.1. By Type of Test
        • 6.3.6.2.2. By Application
        • 6.3.6.2.3. By Product
        • 6.3.6.2.4. By End-User

7. Europe Clinical Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Test
    • 7.2.2. By Application
    • 7.2.3. By Product
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Clinical Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Test
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Product
        • 7.3.1.2.4. By End-User
    • 7.3.2. Germany Clinical Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Test
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Product
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Clinical Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Test
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Product
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Clinical Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Test
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Product
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Clinical Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Test
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Product
        • 7.3.5.2.4. By End-User
    • 7.3.6. Russia Clinical Diagnostics Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Type of Test
        • 7.3.6.2.2. By Application
        • 7.3.6.2.3. By Product
        • 7.3.6.2.4. By End-User

8. North America Clinical Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Test
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Clinical Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Test
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Product
        • 8.3.1.2.4. By End-User
    • 8.3.2. Canada Clinical Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Test
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Product
        • 8.3.2.2.4. By End-User
    • 8.3.3. Mexico Clinical Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Test
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Product
        • 8.3.3.2.4. By End-User

9. South America Clinical Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Test
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Clinical Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Test
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Product
        • 9.3.1.2.4. By End-User
    • 9.3.2. Argentina Clinical Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Test
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Product
        • 9.3.2.2.4. By End-User
    • 9.3.3. Colombia Clinical Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Test
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Product
        • 9.3.3.2.4. By End-User

10. Middle East and Africa Clinical Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Test
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Clinical Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Test
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Product
        • 10.3.1.2.4. By End-User
    • 10.3.2. Saudi Arabia Clinical Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Test
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Product
        • 10.3.2.2.4. By End-User
    • 10.3.3. UAE Clinical Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Test
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Product
        • 10.3.3.2.4. By End-User
    • 10.3.4. Kuwait Clinical Diagnostics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type of Test
        • 10.3.4.2.2. By Application
        • 10.3.4.2.3. By Product
        • 10.3.4.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. BioMerieux SA
    • 13.2.3. Bio-Rad Laboratories Inc.
    • 13.2.4. Danaher Corporation
    • 13.2.5. Becton, Dickinson and Company
    • 13.2.6. F. Hoffmann-La Roche AG
    • 13.2.7. Hologic, Inc.
    • 13.2.8. Thermo Fisher Scientific Inc.
    • 13.2.9. Sysmex Corporation
    • 13.2.10. DiaSorin SpA

14. Strategic Recommendations

15. About Us & Disclaimer